New Ray Medicine International Holding Limited (HKG:6108)

HKG:6108 Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	73.58	29.42	64.26	103.95	154.41	150.15
Trading Asset Securities	-	8	-	-	-	-
Cash & Short-Term Investments	73.58	37.42	64.26	103.95	154.41	150.15
Cash Growth	35.87%	-41.76%	-38.19%	-32.68%	2.84%	128.35%
Accounts Receivable	91.76	82.92	60.39	55.05	34	55.73
Other Receivables	1.53	5.46	5.28	6.13	4.46	9.46
Receivables	93.29	88.37	65.67	61.19	54.41	65.19
Inventory	21.81	23.37	20.1	31.17	35.23	125.31
Other Current Assets	155.47	175.46	177.89	181.89	159.82	143.39
Total Current Assets	344.14	324.62	327.92	378.2	403.87	484.04
Property, Plant & Equipment	28.99	28.21	30.81	29.42	34.38	31.35
Long-Term Investments	97.95	83.68	146.51	79.68	90.15	128.27
Other Intangible Assets	-	-	-	-	4.63	7.01
Other Long-Term Assets	-	-	-	4.31	6.84	11.38
Total Assets	471.08	436.51	505.24	491.6	539.85	662.05

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	20.37	-	21.61	0.34	-	-
Accrued Expenses	5.68	2.91	3.89	4	4.98	6.04
Short-Term Debt	-	-	-	-	-	11.38
Current Portion of Leases	1.24	0.78	1.15	0.29	0.99	0.54
Current Income Taxes Payable	-	-	-	-	-	0.15
Current Unearned Revenue	1.16	1.05	0.03	0.05	1	0.42
Other Current Liabilities	1.11	1.06	0.64	0.87	0.88	0.97
Total Current Liabilities	29.55	5.8	27.31	5.56	7.85	19.49
Long-Term Leases	0.88	1.68	2.4	-	0.29	0.92
Long-Term Deferred Tax Liabilities	4.81	4.81	4.56	5.8	6.05	9.06
Total Liabilities	35.23	12.29	34.28	11.35	14.19	29.48

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2.01	2.01	83.59	83.59	83.59	83.59
Additional Paid-In Capital	433.84	746.78	657.78	657.78	657.78	657.78
Retained Earnings	-	-114.19	-94.17	-63.15	-40.49	39.29
Comprehensive Income & Other	-	-210.37	-176.25	-197.97	-175.23	-148.09
Shareholders' Equity	435.85	424.22	470.96	480.25	525.66	632.57
Total Liabilities & Equity	471.08	436.51	505.24	491.6	539.85	662.05

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2.12	2.47	3.55	0.29	1.28	12.84
Net Cash (Debt)	71.46	34.96	60.71	103.67	153.14	137.31
Net Cash Growth	38.03%	-42.42%	-41.44%	-32.30%	11.52%	116.73%
Net Cash Per Share	0.39	0.21	0.36	0.62	0.92	0.82
Filing Date Shares Outstanding	200.62	200.62	167.18	167.18	167.18	167.18
Total Common Shares Outstanding	200.62	200.62	167.18	167.18	167.18	167.18
Working Capital	314.59	318.82	300.61	372.64	396.02	464.54
Book Value Per Share	2.17	2.11	2.82	2.87	3.14	3.78
Tangible Book Value	435.85	424.22	470.96	480.25	521.03	625.56
Tangible Book Value Per Share	2.17	2.11	2.82	2.87	3.12	3.74
Buildings	-	10.76	10.5	10.73	10.88	8.6
Machinery	-	17.55	17.91	18.8	20.01	17.24

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 13, 2026

Data Sources Report a data error